Stock GHSI GUARDION HEALTH SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Guardion Health Sciences, Inc.

Equities

GHSI

US40145Q5009

Pharmaceuticals

Delayed Nasdaq
Other stock markets
 03:14:43 2024-06-05 pm EDT 		5-day change 1st Jan Change
9.8 USD +2.62% Intraday chart for Guardion Health Sciences, Inc. +8.38% +83.52%
May. 31 Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc.. CI
May. 13 Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 16.52 36.66 15.81 8.938 6.81
Enterprise Value (EV) 1 5.99 28.57 6.743 -1.713 0.4501
P/E ratio -0.74 x -4.14 x -0.62 x -0.51 x 42.9 x
Yield - - - - -
Capitalization / Revenue 18.3 x 19.4 x 2.19 x 0.81 x 0.56 x
EV / Revenue 6.63 x 15.1 x 0.93 x -0.16 x 0.04 x
EV / EBITDA -0.71 x -3.16 x -0.7 x 0.28 x -0.11 x
EV / FCF -2.03 x -5.61 x -1.02 x 0.21 x 1.36 x
FCF Yield -49.2% -17.8% -98.3% 476% 73.7%
Price to Book 1.37 x 4.44 x 0.71 x 1.16 x 0.84 x
Nbr of stocks (in thousands) 250 294 489 1,232 1,275
Reference price 2 66.09 124.5 32.36 7.255 5.340
Announcement Date 3/30/20 3/26/21 3/31/22 4/17/23 3/29/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.9422 0.9029 1.89 7.233 11.05 12.25
EBITDA 1 -5.848 -8.456 -9.053 -9.7 -6.072 -3.922
EBIT 1 -6.144 -8.742 -9.118 -10.48 -7.321 -3.942
Operating Margin -652.09% -968.17% -482.49% -144.94% -66.26% -32.18%
Earnings before Tax (EBT) 1 -7.767 -10.88 -8.572 -24.75 -14.92 0.158
Net income 1 -7.767 -10.88 -8.572 -24.75 -14.92 0.158
Net margin -824.43% -1,204.77% -453.56% -342.11% -135.05% 1.29%
EPS 2 -115.4 -89.49 -30.06 -52.23 -14.15 0.1244
Free Cash Flow 1 -2.178 -2.949 -5.093 -6.626 -8.156 0.3319
FCF margin -231.18% -326.62% -269.5% -91.61% -73.81% 2.71%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - 210.03%
Dividend per Share - - - - - -
Announcement Date 2/14/19 3/30/20 3/26/21 3/31/22 4/17/23 3/29/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 2.627 2.385 3.275 2.664 2.726 3.186 2.79 3.337 2.936 3
EBITDA - - - - - - - - - -
EBIT 1 -14.52 -2.62 -1.712 -1.739 -11.35 -1.464 -1.013 -0.7729 -1.087 -1.554
Operating Margin -552.67% -109.87% -52.26% -65.3% -416.29% -45.96% -36.3% -23.16% -37.02% -51.8%
Earnings before Tax (EBT) - - -1.702 -1.696 - - -1.172 - - -
Net income 1 -14.52 -2.618 -1.702 -1.696 -9.847 0.5331 -1.172 0.3726 0.4247 -4.747
Net margin -552.63% -109.81% -51.96% -63.68% -361.18% 16.73% -42.02% 11.17% 14.47% -158.24%
EPS 2 -30.00 -3.500 -1.500 -1.500 -7.650 0.4200 -0.9300 0.2900 0.3300 -3.710
Dividend per Share - - - - - - - - - -
Announcement Date 3/31/22 5/12/22 8/11/22 11/14/22 4/17/23 5/15/23 8/14/23 11/13/23 3/29/24 5/13/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.67 10.5 8.08 9.06 10.7 6.36
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -2.18 -2.95 -5.09 -6.63 -8.16 0.33
ROE (net income / shareholders' equity) -154% -143% -83.4% -161% -84.2% 1.48%
ROA (Net income/ Total Assets) -69.5% -66% -50.1% -39.3% -20.3% -14.7%
Assets 1 11.18 16.48 17.1 62.92 73.62 -1.078
Book Value Per Share 2 46.50 48.10 28.10 45.60 6.250 6.390
Cash Flow per Share 2 9.790 44.50 28.10 8.380 8.410 4.990
Capex 1 0.26 0.17 0.04 0.07 0.01 0
Capex / Sales 27.62% 18.95% 2.16% 1.03% 0.05% 0.03%
Announcement Date 2/14/19 3/30/20 3/26/21 3/31/22 4/17/23 3/29/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GUARDION HEALTH SCIENCES, INC. Stock Guardion Health Sciences, Inc.
+83.52% 12.26M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.93% 750B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 606B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.85% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.05% 326B
ABBVIE INC. Stock AbbVie Inc.
+6.63% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.08% 246B
ROCHE HOLDING AG Stock Roche Holding AG
-3.44% 213B
NOVARTIS AG Stock Novartis AG
+11.35% 213B
PFIZER, INC. Stock Pfizer, Inc.
+2.52% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GHSI Stock
  4. Financials Guardion Health Sciences, Inc.